Corporate
Description
  • Value proposition

    We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.

    Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.

    For more information, visit ipsen.com.

    Pauta exclusiva para México:
    Clave de Autorización COFEPRIS: 243300201B1962
    CONSULTE A SU MÉDICO.

    Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, and Primary Care

  • Original language

    We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.

    Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.

    For more information, visit ipsen.com.

    Pauta exclusiva para México:
    Clave de Autorización COFEPRIS: 243300201B1962
    CONSULTE A SU MÉDICO.

  • Ipsen Global - A Biopharmaceutical Company | Innovation for Patient Care

    Ipsen Global - A Biopharmaceutical Company | Innovation for Patient Care

  • https://www.ipsen.com/
Entity interactions BETA
Entity TypeTweets Articles
Pôle Saint Hélier Pôle Saint Hélier
healthtech, Hospitals and Health Care
Other

13 Jan 2022


BioLabs BioLabs
Biotechnology Research
Other

1 Apr 2020

2 May 2024



Aitia Aitia
biotech, deeptech, Biotechnology Research
Not capitalistic
Not partnership
Event

22 Apr 2022


L'AGEFI L'AGEFI
Other

27 May 2020


Outwrite PR Outwrite PR
Public Relations and Communications Services
Other

20 Nov 2015


CHEManager International CHEManager International
Newspaper Publishing
Other

28 Feb 2022


PharmaMar PharmaMar
biotech, deeptech, Biotechnology Research
Not capitalistic
Partnership
Event

2 Jul 2018


Fondation Notre Dame Fondation Notre Dame
edtech, Civic and Social Organizations
Other

7 Mar 2016


AKTEHOM AKTEHOM
consulting, regtech, Pharmaceutical Manufacturing
Not capitalistic
Partnership
Event

25 Mar 2021


NewYorkBIO NewYorkBIO
Biotechnology Research
Other

4 Nov 2021


Radars
Loading...